Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful ...

Pompe disease is a rare, progressive neuromuscular disease, with infantile onset being the most aggressive form ...

Patients who had received only one prior line of systemic therapy showed a stronger trend for overall survival and ...

Women in Healthcare Leadership podcast series. Now on its fourth series, “Hear from Her” has established itself globally as ...

For pharma, its AI progress appears to be slowed by a methodical procession of AI adoption through a series of chicanes.

Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies ...

Oxford BioTherapeutics (OBT) has announced two clinical milestones from its long-running oncology collaboration with ...

Zymeworks, a biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of ...

Global Pricing Innovations supports price decision-making through data-driven insights and bespoke analytical solutions. GPI tools and services maximize clients’ price and value understanding and ...

AbbVie has announced it will acquire Apogee and its diverse pipeline of multiple clinical-stage candidates in development ...

In the emerging framework, a medicine’s value will increasingly depend on how effectively care is delivered around it’ ...

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication ...